Balanced news tone
News Sentiment
MDNA sentiment intelligence
Medicenna Therapeutics Corp. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
77/100 classification confidence.
directly relevant articles
high-authority source matches
-6.3% over one week, -11.9% over four weeks, trend inactive, and below fair value.
What's Going On With Medicenna Therapeutics Corp Stock Wednesday?
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
What's Going On With Medicenna Therapeutics Corp Stock Wednesday?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 03:31
- Source
- Wealth Awesome
Medicenna Therapeutics outlines its cytokine platform strategy as investors watch MDNA
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 14:46
- Source
- ad-hoc-news.de
MDNAF SEC Filings - Medicenna Therapeutics Corp 10-K, 10-Q, 8-K Forms
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Stock Titan
Medicenna Therapeutics explores its cancer pipeline as investors watch clinical progress
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 16:15
- Source
- ad-hoc-news.de
TSX Insights Medicenna Therapeutics And 2 Other Promising Penny Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Feb 2026 08:00
- Source
- Market source
Here's Why We're Watching Medicenna Therapeutics' (TSE:MDNA) Cash Burn Situation
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 26 Jan 2026 08:00
- Source
- Market source
Medicenna Therapeutics Reports Second Quarter Fiscal 2026 Financial Results and Provides a Corporate Update
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Nov 2025 08:00
- Source
- Investing News Network
Medicenna keeps Speculative Buy rating with Research Capital
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 07 Nov 2022 08:00
- Source
- Cantech Letter
Medicenna Therapeutics Stock Price Forecast. Should You Buy MDNA.TO?
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 04 Dec 2020 23:25
- Source
- StockInvest.us